Balchem financials
$168.68+0.47%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $284.0M | $270.7M | $263.6M | $267.6M | $255.5M | $250.5M | $240.0M | $239.9M | $234.1M | $239.7M | $228.7M | $229.9M |
| Gross profit | $103.7M | $101.1M | $93.9M | $95.5M | $93.1M | $88.2M | $86.3M | $85.4M | $83.0M | $81.5M | $75.0M | $76.5M |
| Gross margin | 36.5% | 37.3% | 35.6% | 35.7% | 36.4% | 35.2% | 36.0% | 35.6% | 35.5% | 34.0% | 32.8% | 33.3% |
| Operating income | $59.2M | $55.6M | $52.3M | $54.6M | $51.4M | $51.0M | $47.4M | $48.0M | $45.8M | $41.7M | $38.3M | $43.6M |
| Net income | $44.6M | $40.3M | $39.2M | $40.3M | $38.3M | $37.1M | $33.6M | $33.8M | $32.1M | $29.0M | $26.6M | $29.1M |
| Net margin | 15.7% | 14.9% | 14.9% | 15.1% | 15.0% | 14.8% | 14.0% | 14.1% | 13.7% | 12.1% | 11.7% | 12.6% |
| Diluted EPS | $1.39 | $1.25 | $1.21 | $1.24 | $1.17 | $1.13 | $1.02 | $1.03 | $0.98 | $0.89 | $0.82 | $0.90 |
| EBITDA | $71.4M | $68.1M | $64.0M | $66.1M | $62.8M | $62.0M | $58.3M | $58.9M | $58.3M | $55.3M | $52.4M | $57.4M |
| Operating cash flow | $46.7M | $40.1M | $67.3M | $65.6M | $47.3M | $36.5M | $52.3M | $51.3M | $45.0M | $33.4M | $78.7M | $46.5M |
| Free cash flow | $35.8M | $33.8M | $51.1M | $50.7M | $40.4M | $30.9M | $39.6M | $42.2M | $38.1M | $26.5M | $67.0M | $38.2M |
| Diluted shares | 32.2M | 32.3M | 32.3M | 32.6M | 32.7M | 32.8M | 32.8M | 32.8M | 32.6M | 32.6M | 32.5M | 32.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $63.2M | $72.9M | $74.6M | $65.1M | $65.4M | $49.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $176.2M | $192.3M | $187.2M | $177.1M | $212.5M | $211.8M |
| Total assets | $1.69B | $1.69B | $1.69B | $1.66B | $1.68B | $1.62B |
| Total liabilities | $384.6M | $408.6M | $428.8M | $363.2M | $410.3M | $408.9M |
| Shareholders' equity | $1.30B | $1.29B | $1.26B | $1.30B | $1.27B | $1.21B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology